Research halted at Seattle hospital

Officials have halted enrollment in more than 600 human research studies taking place in Seattle this week after a federal audit found shoddy paperwork in some consent forms. The Department of Veterans Affair's linkurl:Office of Research Oversight;http://www1.va.gov/oro/ determined in a November audit that the linkurl:VA Puget Sound Health Care System;http://www1.va.gov/pugetsound/ should be more careful in documenting that human subjects are competent enough to make reasoned informed consent.

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Officials have halted enrollment in more than 600 human research studies taking place in Seattle this week after a federal audit found shoddy paperwork in some consent forms. The Department of Veterans Affair's linkurl:Office of Research Oversight;http://www1.va.gov/oro/ determined in a November audit that the linkurl:VA Puget Sound Health Care System;http://www1.va.gov/pugetsound/ should be more careful in documenting that human subjects are competent enough to make reasoned informed consent. Local oversight committees were also censured for not formally judging risk levels on a study by study basis.
"This is a procedural issue," Norm Arkan, a University of Washington spokesperson, told __The Scientist__. "There were no issues here of any subject being in jeopardy with regard to safety issues." "There were administrative oversight issues, and we've begun the process of making changes," added Jeri Rowe, the VA Puget Sound Health Systems' director of public affairs. Researchers can continue collecting data from patients already enrolled in ongoing studies but cannot add new subjects or publish any results until the hospital cleans up its documentation methods, according to the__ linkurl:Seattle Post-Intelligencer.;http://seattlepi.nwsource.com/local/6420ap_wa_va_research.html __The decision applies to about 600 studies being conducted at the hospital and at the University of Washington, and 15 studies at the Fred Hutchinson Cancer Research Center that were actively recruiting bone-marrow transplant and oncology patients at the hospital. Arkan expects that the studies will now be delayed by "several weeks." In the meantime, researchers may have to turn to data analysis and other minor research-related tasks until the wrinkles are ironed out. "The biggest impediment," he said, will be that "our researchers have a lot of paperwork to fill out," but the research will resume eventually.
**__Related stories:__***linkurl:Research halted at UConn neuro lab;http://www.the-scientist.com/news/display/49079/
[6th February 2007]*linkurl:Focus on Seattle;http://www.the-scientist.com/article/display/15141/
[6th December 2004]*linkurl:Research and human subjects;http://www.the-scientist.com/article/display/12054/
[2nd October 2000] *linkurl:Research suspended at Los Angeles VA center;http://www.the-scientist.com/article/display/18491/
[12th April 1999]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies